Circulars

• General Information on antibiotics and antibiotic resistance

• Special drive for assuring the quality of the medicines manufactured in the country - regarding.

• Important safety label changes to cholesterol- lowering statin drug

• "Box Warning" on label as well as package insert and other promotional literature of formulations containing Nimesulide-regarding

• Clarification regarding Limiting of Acetaminophen (Paracetamol) in prescription combination products - regarding

• Guidance document for Functions and Responsibilities of Zonal, Sub-zonal & port offices of CDSCO

• Suspension of import / manufacture of rosiglitazone in the country 

•  Prohibition of manufacture & sale of Rosiglitazone 

•  Information required for submission to Department related Parliament Standing Committee on  H&FW

• Drugs Prohibited vide Gazette notification, Feb 10, 2011  (G.S.R.82(E))

• CRO Draft , Jan 19, 2011 (G.S.R 40 (E))

• New Drugs, Jan, 24, 2011 (G.S.R 45 (E))

• Phasing out of oral Single Drug Formulations of Artemisinin

• Limiting of Acetaminophen (Paracetamol) in Prescription Combination Products - regarding

• Cosmetic NOC